US Patent 9399069 17-Hydroxyprogesterone ester containing oral compositions and related methods
Patent 9399069 was granted and assigned to Lipocine Inc. on July, 2016 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9399069 17-Hydroxyprogesterone ester containing oral compositions and related methods
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
